Physician profile
Justin Lee Gooden
NPI 1205127982
$11,417.57
in general payments reported to CMS, 2019-2025
21 companies · $5,743 in 2025
The $5,743 reported for 2025 was more than what 94% of Undersea and Hyperbaric Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $119 · 2021: $371 · 2022: $935 · 2023: $1,800 · 2024: $2,336 · 2025: $5,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,548 · Travel and Lodging: $3,014 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,547.64 |
| Travel and Lodging | $3,013.95 |
| Education | $316.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,960.24 | 2024-2025 | |
| Kerecis Limited | $2,934.89 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $2,489.14 | 2019-2025 | Collagenase Santyl, Oasis, Renasys Go V2 Home |
| Organogenesis INC. | $1,187.49 | 2019-2024 | Puraply, Affinity, Puraply Am |
| Surgenex LLC | $507.89 | 2025 | Renograft, Ardeograft, Surgraft |
| Paratek Pharmaceuticals, INC. | $357.57 | 2023-2025 | Nuzyra |
| Convatec INC. | $251.62 | 2021-2024 | |
| Next Science LLC | $175.64 | 2023-2024 | Surgx, Blastx, Xperience |
| Abbvie INC. | $103.87 | 2023-2025 | |
| Hydrofera LLC | $86.92 | 2022-2023 | Hydrofera Blue |
| Kci USA, INC. | $62.51 | 2020-2021 | |
| Integra Lifesciences Corporation | $57.97 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Urgo Medical North America, LLC | $41.82 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Bsn Medical INC | $41.13 | 2024-2025 | |
| Solventum Corporation | $32.22 | 2024 | Activ.A.C. |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $28.74 | 2024 | Qutenza |
| Coloplast Corp | $23.97 | 2024 | |
| Polynovo North America LLC | $19.92 | 2024 | Novosorb Btm |
| Heron Therapeutics, INC. | $19.50 | 2024 | Zynrelef |
| Apria Healthcare LLC | $17.91 | 2021 | |
| Reprise Biomedical, INC. | $16.61 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Gooden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.